Trademark information
IP India · live recordApplication ID
3629858
Status
Registered
Sub status
Not Applicable
Date of application
07 September 2017
Classes
5
Type
Word
Proprietor
Glenmark Pharmaceuticals Public
B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026
Attorney
Vishesh And Associates[10756]301/302, A Wing, 3 Rd Floor, Shaheen Chambers, Dawood Baug, Opp. Pearl Heritage,Andheri (West), Mumbai 400 058.
State
Maharashtra
Filing mode
e-Filing
IP office
Mumbai
Used since
—
Valid / upto
07 September 2027
Goods & services
Class 5Class 5PHARMACEUTICAL, MEDICINAL AND AYURVEDIC PREPARATIONS AND SUBSTANCES, DIETETIC FOOD AND SUBSTANCES ADAPTED FOR MEDICAL USE, DIETARY SUPPLEMENTS FOR HUMANS, NUTRITIONAL SUPPLEMENTS, NUTRACEUTICAL PREPARATIONS FOR THERAPEUTIC OR MEDICAL PURPOSES, NUTRACEUTICALS FOR USE AS DIETARY SUPPLEMENTS, GLUCOSE FOR MEDICINAL PURPOSE, MEDICAL DIAGNOSTIC TEST STRIPS
PR details
GLENMARK PHARMACEUTICALS LTD, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026, BODY INCORPORATE - Company registered under the Companies Act, 1956, (Body Incorporate)
Uploaded documents
Sign in to open
1
TM-A(TRADE MARKS APPLICATION)
07 Sep 2017
2
Reply to Exam Report (MIS-R)
24 Oct 2017
3
Authorization Letter
11 Apr 2019
4
Journal Copy
25 Jun 2019
5
TM-O(NOTICE OF OPPOSITION)
20 Aug 2019
6
Order
28 Oct 2021
7
Certificate
23 Jan 2022
8
TM-M(CERTIFICATIE OF REGISTER (U/S 137) / CERTIFIED COPY OF A DOCUMENT)
20 Jan 2023
Correspondence and notices
1
Hearing Notice (Show Cause)
7875934 · 3921317
28 Feb 2019
2
Tribunal Accepted Notice for : 3629858
8109325 · 3987145
11 Apr 2019
3
Opposition Notice
8851401 · 4361067
29 Aug 2019
4
Opposition Counter Statement
9160216 · 4495807
26 Oct 2019
5
Hearing Notice
12219975 · 5321611
27 Sep 2021
Frequently asked questions
Instacount was applied for on 07 September 2017.
The application was filed by Glenmark Pharmaceuticals.
Class 5.
As per IP India, the status is Registered.
The listed application ID of Instacount is 3629858.
Trademark attorney Vishesh And Associates.